PV7-33121-58073
3 vaccinations
3 coded responses
44 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 191 / PA
- Registered
- 2021-03-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-26
Dose 1 — Janssen/Johnson & Johnson
-
2021-03-27
Registered in v-safe
-
2021-03-27
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-28
-
2021-03-29
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-03-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-06-26
- 2021-09-25
-
2021-10-30
Dose 2 — Moderna
- 2021-10-30
-
2021-10-31
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-05
- 2021-11-06
-
2021-11-13
Survey response — day 14, dose 2MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
- 2021-11-20
- 2021-11-27
- 2021-12-04
- 2021-12-11
-
2022-01-29
Survey response — 3 months, dose 2MedDRA: Nasopharyngitis — Feeling: Good · Be unable to do your normal daily activitiesFree text: A bad, lingering cold.MedDRA releases: 2024-11 · check-in free text available
- 2022-04-30
-
2022-10-22
Dose 3 — Pfizer-BioNTech
- 2022-10-22
-
2022-10-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
- 2022-10-24
- 2022-10-25
- 2022-10-26
- 2022-10-27
- 2022-10-28
- 2022-10-29
- 2022-11-05
- 2022-11-12
- 2022-11-19
- 2022-11-26
- 2022-12-03
- 2023-01-21
- 2023-04-24
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-26 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-30 | Moderna | No |
| 3 | 2022-10-22 | Pfizer-BioNTech | No |
Free text
Release 10 — day 14, dose 2
Symptoms: Runny nose
Release 11 — 3 months, dose 2
Symptoms: A bad, lingering cold.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release